pages_kennzahlen_[key]_[isin]__meta_title

Myriad Genetics Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_dividenden_[isin]_index__2

components_kpi_DebtFaqs_0

components_kpi_DebtFaqs_1

components_kpi_DebtFaqs_2

components_kpi_DebtFaqs_3

components_kpi_DebtFaqs_4

components_kpi_DebtFaqs_5

components_kpi_DebtFaqs_6

components_kpi_DebtFaqs_7

components_kpi_DebtFaqs_8

components_kpi_DebtFaqs_9

components_kpi_DebtFaqs_10

components_kpi_DebtFaqs_11

components_kpi_DebtFaqs_12

components_kpi_DebtFaqs_13

components_kpi_DebtFaqs_14

components_kpi_DebtFaqs_15

components_kpi_DebtFaqs_16

components_kpi_DebtFaqs_17

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Myriad Genetics kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

Myriad Genetics base_Schulden 2025

Myriad Genetics base_Schulden

components_StockPageHeader__3

components_StockPageHeader__4

components_StockPageHeader__5

pages_kennzahlen_[key]_[isin]__42